A novel combination for relapsed/refractory multiple myeloma produced responses in about 80% of a heavily treated population, ...

A plant-based diet invention high in fibre may slow the spread of multiple myeloma, a rare, incurable blood cancer, in ...

is a cancer affecting a particular type of blood cells, called plasma cells. Myeloma is most common in people over 60 and is characterized by the accumulation of abnormal plasma cells in the bone ...

Denosumab is given by injection every four weeks. It increases bone density by blocking the activity of osteoclasts, a type of cell that breaks down bones. A 2016 review of studies looked at three ...

Background: Multiple myeloma (MM) is a hematological malignancy characterized by bone marrow infiltration and osteolytic tumor formation. Despite advancements in the treatment of this disease, MM ...

he will also oversee the expansion of Northwell’s multiple myeloma clinical and research programs. Dr. Chung joins Northwell Health from Memorial Sloan-Kettering Cancer Center (MSK), where he was a ...

Graham Casey, from Bearsden in East Dunbartonshire, was 63 when he was diagnosed with myeloma - a form of blood cancer - in October 2022. The disease had left him barely able to move or sleep ...

GSK has gained US FDA breakthrough therapy designation for GSK'227 to treat adults with relapsed or refractory osteosarcoma.

After a bone marrow biopsy and blood tests, he was diagnosed with a rare, incurable cancer called multiple myeloma, which affects a type of white blood cell, called plasma cells, that play a key ...

“We believe that specifically targeting these two RANK motifs has the potential to serve as effective and selective therapeutic targets for bone lesions in multiple myeloma.” The R21 grant supporting ...